Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: J Urol. 2017 Jul 18;199(1):98–105. doi: 10.1016/j.juro.2017.07.038

Figure 3.

Figure 3

Upgrade rate to Gleason Score (GS) ≥ 3+4 on repeat biopsy, stratified by biopsy method (systematic, MRI target, systematic tracking, and MRI target tracking). Percent on top of each bar represents total upgrade rate when patients with baseline GS 3+3 and GS 3+4 are combined.